PDS Biotechnology Corp Issues Shareholder Letter (Regulation FD)

What Happened
PDS Biotechnology Corporation (PDSB) filed a Form 8-K on August 11, 2026 to disclose a letter to shareholders that was posted on the company’s Investor Relations website (pdsbiotech.com/index.php/investors). The disclosure was made under Item 7.01 (Regulation FD Disclosure) and the shareholder letter is furnished as Exhibit 99.1 and incorporated by reference.

Key Details

• Filing date: August 11, 2026 (Form 8-K).
• Disclosure type: Regulation FD — shareholder letter made public.
• Where posted: PDSB Investor Relations page: pdsbiotech.com/index.php/investors.
• Exhibit: Shareholder Letter dated August 11, 2026 furnished as Exhibit 99.1 (and Inline XBRL cover page 104 included).

Why It Matters
This 8-K confirms the company provided the same shareholder communication to the public under Regulation FD, ensuring broad, non-selective disclosure. Retail investors should read the posted shareholder letter (Exhibit 99.1) for any updates or material information; the 8-K itself does not report earnings, management changes, or other financial details beyond furnishing the letter.